CNP
49
7
SPG
63
7
XRX
37
2
LUV
45
2
XRAY
29
3
ADBE
45
-2
FMC
41
-3
EMN
50
-5
DD
60
-7
HSY
34
3
TGNA
64
-2
COST
66
6
RCL
87
4
LB
82
19
DE
35
-13
ISRG
77
2
CINF
48
3
PNW
66
3
DG
10
2
FOXA
66
2
CNP
49
7
SPG
63
7
XRX
37
2
LUV
45
2
XRAY
29
3
ADBE
45
-2
FMC
41
-3
EMN
50
-5
DD
60
-7
HSY
34
3
TGNA
64
-2
COST
66
6
RCL
87
4
LB
82
19
DE
35
-13
ISRG
77
2
CINF
48
3
PNW
66
3
DG
10
2
FOXA
66
2
Financhill
Back

Summit Therapeutics Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
65

SMMT
Summit Therapeutics

Last Price:
21.41
Seasonality Move:
43.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Summit Therapeutics Stock Forecast

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 111.1% based on the past 9 years of stock performance.
  • Summit Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Summit Therapeutics Stock Undervalued?
    The current Summit Therapeutics [SMMT] share price is $21.41. The Score for SMMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 111.1% based on the past 9 years of stock performance.

Summit Therapeutics Stock Rating

Buy
65
Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics overpriced?

  • Summit Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com

52-Week Data

52-Week High:
33.89
52-Week Low:
1.75

Prediction Charts

Market Cap:
15.79B
Price in USD:
21.41
Volume:
1.73M
Beta:
-0.24

Technical Analysis

SMA50:
20.55
SMA100:
15.24
SMA200:
9.96
52-Wk Change:
1073.15%

Stock Predictions

  • Is Summit Therapeutics stock public?
    Yes, Summit Therapeutics is a publicly traded company.
  • What is the Summit Therapeutics stock quote today?
    The Summit Therapeutics stock price is 21.41 USD today.
  • How to buy Summit Therapeutics stock online?
    You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-22 20.41 20.59 20.91 20.20
Oct-23 20.41 20.03 20.57 19.34
Oct-24 20.06 19.46 20.75 19.43
Oct-25 19.69 21.26 21.54 19.68
Oct-28 21.41 22.24 22.90 21.26
Oct-29 21.76 21.83 22.30 21.11
Oct-30 21.00 18.65 21.18 18.60
Oct-31 18.75 18.59 19.42 18.10
Nov-1 18.98 18.99 19.77 18.61
Nov-4 19.41 19.96 20.56 18.80
Nov-5 20.10 20.39 20.55 19.70
Nov-6 20.16 20.89 20.96 19.01
Nov-7 21.19 21.10 21.68 20.26
Nov-8 21.21 21.41 21.83 20.72

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.08 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.